Co-Occurrence of ANCA-Associated Vasculitis and Sjögren's Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.
ANCA
PTPN22
Sjögren
acromegaly
autoantibodies
microscopic polyangiitis
small vessel vasculitis
whole exome sequencing
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
01
10
2020
accepted:
20
11
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
23
6
2021
Statut:
epublish
Résumé
ANCA-associated vasculitis (AAV) and Sjögren's syndrome (SS) are uncommon autoimmune diseases. The co-occurrence in the same patient has been rarely described. Acromegaly has been associated with autoimmune thyroiditis, but the prevalence of other autoimmune disorders such as AAV and SS has not been evaluated in acromegaly. Characterization of a patient with acromegaly and two rare autoimmune diseases-SS and AAV (microscopic polyangiitis (MPA))-by autoantibody-array and whole exome sequencing (WES). Single-center retrospective review of medical records of acromegaly patients to explore the prevalence of diagnosed autoimmune diseases. We report a Caucasian woman in her 50's with a serologically (anti-SSA/Ro, anti-MPO-ANCA antibodies) and histologically confirmed diagnosis of symptomatic SS and MPA. SS with MPO-ANCA positivity preceded MPA. An exploratory autoantigen array detected a broad spectrum of autoantibodies. WES revealed heterozygous carrier status of the PTPN22 mutation R620W, which is associated with an increased risk for autoimmunity. A similar combination of positive anti-SSA/Ro autoantibodies and ANCA was only present in 5/1184 (0.42%) other patients tested for both antibodies in our clinic over six years. Amongst 85 acromegaly patients seen at our clinic in a 20-year period, 12% had a clinically relevant associated immunological disease. We present a rare case of SS and AAV in a patient with acromegaly and multiple autoantibody specificities. Patients with SS and ANCA should be closely monitored for the development of (subclinical) AAV. Whether acromegaly represents a risk for autoimmunity should be further investigated in prospective acromegaly cohorts.
Sections du résumé
Background
ANCA-associated vasculitis (AAV) and Sjögren's syndrome (SS) are uncommon autoimmune diseases. The co-occurrence in the same patient has been rarely described. Acromegaly has been associated with autoimmune thyroiditis, but the prevalence of other autoimmune disorders such as AAV and SS has not been evaluated in acromegaly.
Methods
Characterization of a patient with acromegaly and two rare autoimmune diseases-SS and AAV (microscopic polyangiitis (MPA))-by autoantibody-array and whole exome sequencing (WES). Single-center retrospective review of medical records of acromegaly patients to explore the prevalence of diagnosed autoimmune diseases.
Results
We report a Caucasian woman in her 50's with a serologically (anti-SSA/Ro, anti-MPO-ANCA antibodies) and histologically confirmed diagnosis of symptomatic SS and MPA. SS with MPO-ANCA positivity preceded MPA. An exploratory autoantigen array detected a broad spectrum of autoantibodies. WES revealed heterozygous carrier status of the PTPN22 mutation R620W, which is associated with an increased risk for autoimmunity. A similar combination of positive anti-SSA/Ro autoantibodies and ANCA was only present in 5/1184 (0.42%) other patients tested for both antibodies in our clinic over six years. Amongst 85 acromegaly patients seen at our clinic in a 20-year period, 12% had a clinically relevant associated immunological disease.
Conclusion
We present a rare case of SS and AAV in a patient with acromegaly and multiple autoantibody specificities. Patients with SS and ANCA should be closely monitored for the development of (subclinical) AAV. Whether acromegaly represents a risk for autoimmunity should be further investigated in prospective acromegaly cohorts.
Identifiants
pubmed: 33408719
doi: 10.3389/fimmu.2020.613130
pmc: PMC7779546
doi:
Substances chimiques
Antibodies, Antineutrophil Cytoplasmic
0
Autoantibodies
0
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
613130Informations de copyright
Copyright © 2020 Fuchs, Lötscher, Berkemeier, Hirsiger, Ghosh, Li, Deigendesch, Christ, Navarini, Recher, Daikeler, Heijnen and Berger.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Growth Horm IGF Res. 2009 Jun;19(3):187-97
pubmed: 19144554
Nat Rev Rheumatol. 2014 Oct;10(10):602-11
pubmed: 25003765
J Endocrinol Invest. 2020 Nov;43(11):1661-1667
pubmed: 32333332
Arthritis Rheum. 2012 Jul;64(7):2319-27
pubmed: 22237992
Arthritis Rheumatol. 2019 Apr;71(4):486-495
pubmed: 30507064
Pituitary. 2015 Dec;18(6):912-5
pubmed: 26163018
Autoimmun Rev. 2015 Aug;14(8):742-50
pubmed: 25916811
N Engl J Med. 2007 Mar 22;356(12):1216-25
pubmed: 17377159
J Clin Med. 2019 Mar 12;8(3):
pubmed: 30871019
Genes Immun. 2005 Oct;6(7):628-31
pubmed: 16163373
N Engl J Med. 2014 Dec 18;371(25):2363-74
pubmed: 25470569
Arthritis Rheumatol. 2017 May;69(5):1054-1066
pubmed: 28029757
Genes Immun. 2005 Aug;6(5):457-8
pubmed: 15933742
Am J Hum Genet. 2005 Apr;76(4):561-71
pubmed: 15719322
Br J Rheumatol. 1988 Jun;27(3):242-3
pubmed: 3378130
Autoimmune Dis. 2012;2012:254319
pubmed: 22454759
Clin Immunol. 2016 Dec;173:157-160
pubmed: 27810512
Pituitary. 2017 Feb;20(1):4-9
pubmed: 27743174
Nat Genet. 2013 Nov;45(11):1284-92
pubmed: 24097067
Immunity. 2020 Apr 14;52(4):650-667.e10
pubmed: 32294406
Ann Rheum Dis. 2015 Nov;74(11):1983-9
pubmed: 24938285
Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2158-2170
pubmed: 28583713
J Clin Invest. 2020 Oct 1;130(10):5326-5337
pubmed: 32634122
Oral Dis. 2000 Jan;6(1):31-4
pubmed: 10673785